# Artificial Tears Study in Mild to Moderate Dry Eye Patients

> **NCT00607776** · PHASE2 · COMPLETED · sponsor: **Abbott Medical Optics** · enrollment: 110 (actual)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** (9587X) Blink Tears, classified as an OTC Drug with the active ingredient being plyethylene glycol 400
- **DRUG:** Systane

## Key facts

- **NCT ID:** NCT00607776
- **Lead sponsor:** Abbott Medical Optics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** —
- **Final completion:** 2007-04
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2025-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00607776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00607776, "Artificial Tears Study in Mild to Moderate Dry Eye Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00607776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*